Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents

Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance

Resminostat in advanced hepatocellular carcinoma (HCC): Overall survival subgroup analysis of prognostic factors in the SHELTER trial.